Frontiers in Oncology (Feb 2023)
Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
- François Poumeaud,
- Anna Fontanier,
- Jérémie Dion,
- Quentin Mathevet,
- Olivier Cointault,
- Emmanuelle Uro-Coste,
- Céline Marty,
- Florence Dalenc,
- Pierre Girardie,
- Anaïs Rataboul
Affiliations
- François Poumeaud
- Department of Medical Oncology, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
- Anna Fontanier
- Department of Clinical Pharmacy, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
- Jérémie Dion
- Department of Internal Medicine and Clinical Immunology, Centre Hospitalier Universitaire Toulouse, Toulouse, France
- Quentin Mathevet
- Department of Clinical Pharmacy, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
- Olivier Cointault
- Department of Nephrology, Centre Hospitalier Universitaire Toulouse, Toulouse, France
- Emmanuelle Uro-Coste
- Department of Anatomo-pathology, Institut Universitaire du Cancer de Toulouse –Oncopole, Toulouse, France
- Céline Marty
- Department of Clinical Pharmacy, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
- Florence Dalenc
- Department of Medical Oncology, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
- Pierre Girardie
- Department of Neurology, Centre Hospitalier Universitai Toulouse –Purpan, Toulouse, France
- Anaïs Rataboul
- Department of Medical Oncology, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
- DOI
- https://doi.org/10.3389/fonc.2023.1149399
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords